The global Transplant Screening Tests Market size is expected to reach USD 7.08 billion by 2028 at a CAGR of 7.5%, according to the latest report by Reports and Data. Global market revenue growth is majorly attributed to surging number of organ transplantation procedures, rise in awareness about organ donation, increasing burden of infectious diseases, and surging prevalence of chronic diseases worldwide. Rising adoption of pre-Transplant Screening Tests, growing demand for high-throughput transplant diagnostic tools, technological advancements in diagnostic solutions, and rising cases of complications associated with organ transplantation are other crucial factors driving demand for Transplant Screening Tests.

Transplant Screening Tests are diagnostic tools and techniques used to improve the effectiveness of transplantation procedures. These techniques are extensively used in pre-transplant screening for donor eligibility, immunogenetics testing, Human Leukocyte Antigen (HLA) tests, etc. They further help to identify post-transplant acute rejection and aid in the management of immunosuppression levels in transplant patients. Furthermore, these tests eliminate chances of several complications such as infection or graft failure. Rising adoption of next-Generation Sequencing (NGS) technology for their advantages over traditional methods like HLA typing, growing adoption of personalized medicine and stem cell therapy, and rise in government funding for healthcare R&D activities are expected to continue to support market growth going ahead.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/4039

Some Key Highlights From the Report:

• The molecular assay technologies segment dominated other technology type segments in the global market in terms of revenue in 2020. Segment revenue is expected to increase significantly over the forecast period due to rising adoption of transplant diagnostic techniques, technological advancements in these methods, and increasing adoption of PCR-based technologies for improved accuracy, lesser turnaround time, real-time sample analysis, and lower risks.
• The independent reference laboratories segment leads among the end-use segments, and is expected to continue to account for largest revenue share over the forecast period. Increasing number of organ transplant procedures, surge in pharmaceutical and biotechnological research & development activities, and rapid automation of diagnostic laboratories are some key factors driving revenue growth of this segment.
• The Transplant Screening Tests market in North America led among other regional markets in the global market in terms of revenue in 2020. Surging number of organ transplant procedures, fast-paced adoption of advanced diagnostic techniques, and increasing government initiatives to raise awareness about organ donation are factors supporting growth of the North America market.

Key Players covered in this report are

Thermo Fisher Scientific Inc., F. Hoffmann-La Roche, Bio-Rad Laboratories, Inc., Abbott Laboratories, Immucor Transplant Screening Tests, Inc., Qiagen N.V., BioMérieux SA, GenDx, Omixon Ltd., Illumina, Inc., Affymetrix, Inc., CareDx, Luminex Corporation, Hologic Inc., Becton, Dickinson and Company, CareDx, Biofortuna, Takara Bio, and BAG Healthcare.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/4039

By Product Type (Revenue, USD Billion; 2018-2028)

• Instruments
• Reagents & Consumables
• Software & Services

By Technology Type (Revenue, USD Billion; 2018-2028)

• Molecular Assay Technologies
• PCR-based Molecular Assays
• Real-time PCR
• Sequence-specific Oligonucleotide-PCR
• Sequence-specific Primer-PCR
• Others
• Sequencing-based Molecular Assays
• Next-generation Sequencing
• Sanger Sequencing
• Others
• Non-molecular Assay Technologies

By Transplant Type (Revenue, USD Billion; 2018-2028)

• Solid Organ Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Liver Transplantation
  • Kidney Transplantation
  • Pancreas Transplantation
  • Others
• Bone marrow Transplantation
• Stem Cell Transplantation
• Soft Tissue Transplantation

By Application (Revenue, USD Billion; 2018-2028)

• Diagnostic Applications
  • Pre-transplantation Diagnostics
    • Blood Profiling
    • Infectious Disease Testing
    • Histocompatibility Testing
  • Post-transplantation Diagnostics
• Research Applications

By End-use (Revenue, USD Billion; 2018-2028)

• Hospitals & Transplant Centers
• Independent Reference Laboratories
• Research Laboratories & Academic Institutes
• Others

Key Regional Markets Covered in the Report:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Spain, France, BENELUX, Rest of Europe)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of Asia Pacific)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Major Points covered in this report are as below:

• The Transplant Screening Tests industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Transplant Screening Tests Market report provides key statistics on the market status of the Transplant Screening Tests manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4039

Thank you for reading our report. To know more about the customization of the report, please get in touch with us and our team will ensure the report is suited to your requirements.

Get Explore Latest Research Report by Reports and Data:

Hematopoietic Stem Cell Transplantation (HSCT) Market @ https://www.biospace.com/article/increase-in-leukemia-and-lymphoma-cases-is-expected-to-drive-hematopoietic-stem-cell-transplantation-hsct-market-revenue-growth-by-2030-reports-and-data/

Myofascial Pain Syndrome Market @ https://www.biospace.com/article/increasing-prevalence-of-myofascial-is-expected-to-drive-myofascial-pain-syndrome-market-growth-by-2030-reports-and-data/

Urothelial Carcinoma Market @ https://www.biospace.com/article/increase-in-the-number-of-people-adopting-unhealthy-lifestyles-is-expected-to-drive-urothelial-carcinoma-market-growth-by-2030-reports-and-data/

Polyangiitis Market @ https://www.biospace.com/article/increasing-drug-approval-and-r-and-d-investment-is-expected-to-drive-polyangiitis-market-growth-by-2030-reports-and-data/

Fanconi Anemia Treatment Market @ https://www.biospace.com/article/rising-prevalence-of-blood-disorders-across-the-globe-is-expected-to-drive-fanconi-anemia-treatment-market-growth-by-2030-reports-and-data/

B - Cell Chronic Lymphocytic Leukemia Treatment Market @ https://www.biospace.com/article/increasing-number-of-clinical-trials-ongoing-to-avail-newer-and-safer-treatment-options-is-expected-to-drive-b-cell-chronic-lymphocytic-leukemia-treatment-market-growth-by-2030-reports-and-data/\

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com